Smith Graham & Co Investment Advisors’s Veradigm Inc. Common Stock MDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding MDRX
Smith Graham & Co Investment Advisors's MDRX Position: Q4 2023 in Review
Smith Graham & Co Investment Advisors reduced its Veradigm Inc. Common Stock (MDRX) stake by 33% in Q4 2023, selling an estimated $2.13M and leaving 352,062 shares worth $3.69M. The position accounts for 0.43% of the portfolio, ranked #114.
Smith Graham & Co Investment Advisors first reported a position in MDRX in Q3 2019 and has held it in 18 quarters since. The position peaked at $15.9M in Q2 2021. 225 funds tracked by Wall St. Rank hold MDRX as of Q4 2023.
- Smith Graham & Co Investment Advisors held 352,062 shares of Veradigm Inc. Common Stock worth $3.69M as of Q4 2023.
- Smith Graham & Co Investment Advisors sold 173,853 Veradigm Inc. Common Stock shares in Q4 2023, an estimated $2.13M.
- Veradigm Inc. Common Stock made up 0.43% of Smith Graham & Co Investment Advisors's portfolio in Q4 2023, its #114 holding.
- Smith Graham & Co Investment Advisors first reported a position in Veradigm Inc. Common Stock in Q3 2019 and has held it in 18 quarters since.
- Smith Graham & Co Investment Advisors's Veradigm Inc. Common Stock position peaked at $15.9M in Q2 2021.
- 225 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q4 2023.
Based on Smith Graham & Co Investment Advisors's 13F filing for Q4 2023, filed 29 Jan 2024.